Peng Nie

Peng Nie


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JZJinyu Zhao
Jinyu Zhao
LTLiang Tian
Liang Tian
BXBin Xia
Bin Xia
NMNingning Mi
Ningning Mi
QHQiangsheng He
Qiangsheng He
WMWenbo Meng
Wenbo Meng
Background: Recent studies have shown that bile acids are essential in irritable bowel syndrome (IBS) pathology, and cholecystectomy has direct effects on bile acid metabolism. However, whether cholecystectomy increases the risk of IBS remains unclear. We aimed to investigate the association between cholecystectomy and IBS risk in the UK Biobank (UKB).Methods: This study is a prospective analysis of 413,472 participants who were free of IBS, inflammatory bowel disease, cancer, or common benign digestive tract diseases. We identified incidents of IBS through self-reporting or links to primary healthcare and hospitalization data. We evaluated hazard ratios (HRs) adjusted for sociodemographic characteristics, health behaviours, comorbidities, and medications.Results: During a median follow-up period of 12.7 years, we observed 15,503 new cases of IBS. Participants with a history of cholecystectomy had a 46% higher risk of IBS than those without (HR = 1.46, 95% CI: 1.32–1.60), and further subtype analysis showed that the risk of IBS with diarrhoea was significantly higher than the risk of IBS without diarrhoea (HR = 1.71, 95% CI: 1.30–2.25 vs. HR = 1.42, 95% CI: 1.28–1.58). The overall covariate-adjusted HRs for IBS were similar between the group with both cholecystectomy and gallstones (HR = 1.45, 95% CI: 1.32–1.58) and the group with cholecystectomy without gallstones (HR = 1.50, 95% CI: 1.36–1.67) when the group without both cholecystectomy and gallstones was used as a reference. The overall covariate-adjusted HR was not significantly different in the group without cholecystectomy with gallstones (HR = 1.18, 95% CI: 0.95–1.47). The positive association of cholecystectomy with IBS risk did not change when stratifying the data based on age, sex, BMI, smoking, alcohol consumption, healthy diet, quality sleep, physical activity, type 2 diabetes, hypertension, hyperlipidaemia, mental illness, NSAID intake, or acid inhibitor intake. Sensitivity analyses, including propensity score matching analysis and lagging the exposure for two or four years, indicated that the effects were robust.Conclusion: Cholecystectomy was associated with a higher risk of IBS, especially IBS with diarrhoea. Additional prospective randomized controlled and experimental studies are warranted to further validate the association and to explore the relevant biological mechanisms.

6 February 2024 in International Journal of Surgery
Verified
Journal Article
Open access
BZBaoping Mm Zhang
Baoping Mm Zhang
PNPeng Nie
Peng Nie
YLYanyan Lin
Yanyan Lin
ZMZelong Mm Ma
Zelong Mm Ma
GMGuogang Mbbs Ma
Guogang Mbbs Ma
WMWenbo Meng
Wenbo Meng
Background: Roux-en-Y reconstruction is a common anastomosis technique during gastrectomy in gastric cancer. There is a lack of studies on gallstones after Roux-en-Y reconstruction gastrectomy. This study investigated the incidence and potential risk factors associated with gallstones after Roux-en-Y reconstructive gastrectomy in gastric cancer. Methods: The study analyzed data from gastric cancer who underwent radical gastrectomy and Roux-en-Y reconstruction at two hospitals between January 2014 and December 2020. The patients fall into distal and total gastrectomy groups based on the extent of gastrectomy. The cumulative event probability curve was plotted using the Kaplan–Meier, and differences in gallstone between groups were evaluated using the Log-Rank. Propensity score matching was applied to construct a balanced total versus distal gastrectomies cohort. A Cox regression was employed to analyze the risk factors for gallstones after Roux-en-Y reconstructive gastrectomy in gastric cancer. Further subgroup analysis was performed. Results: Five hundred thirty-one patients were included in this study, 201 in the distal gastrectomy group and 330 in the total gastrectomy. During the follow-up, gallstones occurred in 170 cases after gastrectomy, of which 145 cases accounted for 85.29% of all stones in the first two years after surgery. Then, to reduce the impact of bias, a 1:1 propensity score matching analysis was performed on the two groups of patients. A total of 344 patients were evaluated, with each subgroup comprising 172 patients. In the matched population, the Cox regression analysis revealed that females, BMI ≥23 kg/m2, total gastrectomy, No.12 lymph node dissection, and adjuvant chemotherapy were risk factors for gallstones after Roux-en-Y reconstructive gastrectomy. Subgroup analysis showed that open surgery further increased the risk of gallstones after total gastrectomy. Conclusion: The incidence of gallstones increased significantly within 2years after Roux-en-Y reconstructive gastrectomy for gastric cancer. Patients with these risk factors should be followed closely after gastrectomy to avoid symptomatic gallstones.

14 February 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YWYongjin Wang
Yongjin Wang
CGChengwang Guo
Chengwang Guo
MZMingze Zhang
Mingze Zhang
XGXi Guo
Xi Guo
GYGuoyuan Yang
Guoyuan Yang
YMYuntao Ma
Yuntao Ma
To compare the clinical efficacy of the “Toumai” surgical robot and conventional laparoscopic inguinal hernia repair in order to inform surgical practice. A retrospective analysis was conducted on clinical data from 50 patients who underwent inguinal hernia repair at the Department of General Surgery, Gansu Provincial Hospital, between January 2022 and October 2023. Among them, 16 patients received robot-assisted repair (robotic group), and 34 underwent conventional laparoscopic repair (laparoscopic group), all via the transabdominal preperitoneal approach. Evaluation indicators included: (1) preoperative baseline characteristics; (2) intraoperative and postoperative outcomes; and (3) postoperative incision healing and adverse events. Outpatient follow-up and clinical re-examination were conducted 1 to 3 months after surgery to assess wound recovery and recurrence. Continuous variables were expressed as mean ± standard deviation or median (M), and analyzed using the t-test; categorical data were compared using the chi-square test. There were no significant differences in baseline characteristics between the robot-assisted and laparoscopic groups, including sex ratio, age, weight, and hernia classification (P > 0.05). Intraoperatively and postoperatively, the robot group had a significantly longer operative time (104.19 ± 18.93 min vs. 90.17 ± 22.31 min), but demonstrated significantly less blood loss (6.94 ± 3.80 mL vs. 12.24 ± 9.31 mL), shorter hospital stay (3.18 ± 0.54 vs. 3.68 ± 0.81 days), lower pain scores (2.06 ± 0.93 vs. 3.03 ± 1.29), and reduced Subjective Mental Load Scale scores (18.12 ± 12.23 vs. 30.17 ± 11.46) compared to the laparoscopic group (all P < 0.05). No intraoperative complications were observed in either group. Follow-up results showed that postoperative recurrence occurred in 1 case in the robot group and 2 cases in the laparoscopic group. Poor incision healing occurred in 0 and 3 cases, and incision pain in 1 and 4 cases, respectively. In this retrospective cohort, Toumai robot-assisted repair was associated with lower estimated blood loss, lower postoperative pain scores, and shorter length of stay, but longer operative time, compared with laparoscopic repair.

24 March 2026 in Cancer Medicine
Verified
Journal Article
Open access
JZJiaqi Zhou
Jiaqi Zhou
CGChengwang Guo
Chengwang Guo
MZMingze Zhang
Mingze Zhang
XGXi Guo
Xi Guo
JWJihong Wang
Jihong Wang
YMYuntao Ma
Yuntao Ma
Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with locally advanced gastric/gastroesophageal junction adenocarcinoma posing significant therapeutic challenges. Neoadjuvant therapy has emerged as a critical strategy to improve surgical outcomes and long‐term survival by reducing tumor burden and eradicating micrometastases. This systematic review integrates evidence from more than 100 clinical trials and 20 meta‐analyses published in recent years. It focuses on new advances in neoadjuvant therapies for gastric cancer, including chemotherapy, radiotherapy, immunotherapy, and targeted therapies, while highlighting emerging combination strategies and unresolved clinical dilemmas.

1 January 2016 in World Chinese Journal of Digestology
Verified
Journal Article
Closed access
PNPeng Nie
Peng Nie
HMHai-Tao Ma
Hai-Tao Ma
JWJi-Hong Wang
Ji-Hong Wang
FSFa-De Su
Fa-De Su

26 August 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MZMingze Zhang
Mingze Zhang
MHMing Hu
Ming Hu
FHFeng He
Feng He
ASAde Su
Ade Su
CGChengwang Guo
Chengwang Guo
PNPeng Nie
Peng Nie
This study aimed to develop and validate a model for predicting Global Leadership Initiative on Malnutrition (GLIM)-defined malnutrition at the 6-month pos